Diabetic Eye Screening Programmes - East of England

Concepts

• east of england
• diabetic eye screening programmes
• leeds
• health services
• england
• nhs england east of england
• east of england region
• diabetic eye screening programmes - east of england
• screening
• pre-procurement market engagement questionnaire

Location

Bedfordshire and Hertfordshire:

Description

NHS England East of England (The Commissioner) seeks to re-commission Diabetic Eye Screening Programmes (DESP) to deliver screening to eligible populations across the East of England region. This notice is placed as a Prior Information Notice (PIN) in order to facilitate engagement with potential providers and relates only to a pre-procurement market engagement questionnaire and event/s. Responses will help to inform the commissioning strategy in respect of geographical delivery (Lots), payment arrangements and the contract term. Consideration is being given to potential lotting strategies, with the outcomes of market engagement being used to inform the final decision. The invitation to tender is likely to be published March/April/May 2023 and the contract is due to begin in April 2024. Additional information: If you are interested in this opportunity, please register on the e-procurement portal, Atamis , and submit a completed provider market engagement questionnaire by 28th December 2022.This exercise is being carried out by Arden GEM CSU on behalf of the Commissioner(s).

Lot Division

CPV Codes

• 85100000 - Health services

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** This notice is placed as a Prior Information Notice (PIN) in order to facilitate engagement with potential providers and relates only to a pre-procurement market engagement questionnaire and event/s. Responses will help to inform the commissioning strategy in respect of geographical delivery (Lots), payment arrangements and the contract term. Objectives of the service: The aim of the Diabetic Eye Screening programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy, at the appropriate stage during the disease process.The eligible population includes patients aged 12 or over diagnosed with diabetes mellitus (excluding gestational diabetes) and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.All NHS diabetic eye screening services (DES) will be provided in accordance with published DES programme standards and speciation. [https://www.gov.uk/government/publications/diabetic-eye-screening-programme-standards]. The aims of the service will be achieved by delivering an evidence-based service that:• Identifies the eligible population and ensures effective delivery with maximum coverage• Is safe, effective, high quality, externally and independently monitored, and quality assured• Leads to earlier detection, appropriate referral, effective treatment and improved outcomes• Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education (CME), continuous professional development (CPD) and quality assurance (EQA) schemes • Has audit and service evaluation embedded in the service• Has a seamless pathway at the interface between screening and diagnosis and a treatment pathway that ensures people are referred promptly and safely to treatment servicesThere are three key elements of service delivery, namely:• Call/recall for all people with diabetes invited for routine digital screening – this is currently undertaken on an annual basis but screening intervals are likely to extend to two years for people at low risk during the contract term in line with national guidance• Digital surveillance where individuals need more frequent screening• Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).There is an expectation that the contract holder(s) for all lots will work with screening and immunisation teams, NHSE commissioners and other system commissioners across the geography/s to maximise collaboration and opportunities for integrated service offer and delivery. If you are interested in this opportunity, please register on the e-procurement portal, Atamis , and submit a completed provider market engagement questionnaire by 28th December 2022.